DARAPRIM
Total Payments
$38,074
Transactions
1,000
Doctors
727
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $38,074 | 1,000 | 727 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $16,885 | 4 | 44.3% |
| Food and Beverage | $16,231 | 990 | 42.6% |
| Consulting Fee | $4,925 | 2 | 12.9% |
| Education | $33.15 | 4 | 0.1% |
Payments by Type
General
$21,189
996 transactions
Research
$16,885
4 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Daraprim | Vyera Pharmaceuticals, LLC | $16,885 | 2 |
Ad
Manufacturing Companies
- Vyera Pharmaceuticals, LLC $38,074
Product Information
- Type Drug
- Total Payments $38,074
- Total Doctors 727
- Transactions 1,000
About DARAPRIM
DARAPRIM is a drug associated with $38,074 in payments to 727 healthcare providers, recorded across 1,000 transactions in the CMS Open Payments database. The primary manufacturer is Vyera Pharmaceuticals, LLC.
Payment data is available from 2017 to 2017. In 2017, $38,074 was paid across 1,000 transactions to 727 doctors.
The most common payment nature for DARAPRIM is "Unspecified" ($16,885, 44.3% of total).
DARAPRIM is associated with 1 research study, including "Daraprim" ($16,885).